Biotech

HealthPharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By Lindsey LeakeJanuary 16, 2025

By Robert Langreth and BloombergDecember 18, 2024

HealthArnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation
By Lindsey LeakeNovember 13, 2024

Leadership23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By Lila MacLellanOctober 17, 2024

By Alexa MikhailOctober 6, 2024

By Lindsey LeakeSeptember 24, 2024

By Amy Taxin, Terry Chea and The Associated PressSeptember 1, 2024

HealthSergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
By Marco Quiroz-GutierrezJuly 23, 2024

By Allie GarfinkleJune 27, 2024

TechMeta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream
By Sharon GoldmanJune 25, 2024
CommentaryVerge Genomics CEO: Why I urge my employees to share their fears and vulnerabilities—and do the same with them
By Alice ZhangJune 5, 2024

NewslettersThe finance chief of this biotech company is a Harvard-trained neuroscientist who says ‘the modern day CFO needs to speak the language of the team’
By Sheryl EstradaMay 9, 2024

By Sage LazzaroApril 25, 2024
Most Popular




